Biora Therapeutics, Inc. (BIORQ) — Cash Flow Quality Index

Latest as of September 2024: -0.10x

Biora Therapeutics, Inc. (BIORQ) has a Cash Flow Quality Index of -0.10x as of September 2024. Operating cash flow of $-8.73 Million is below net income of $90.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BIORQ debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.10x

Operating CF / Net Income

Operating Cash Flow

$-8.73 Million

USD

Net Income

$90.56 Million

USD

Data as of

Sep 2024

Most recent filing

Annual Cash Flow Quality Index for Biora Therapeutics, Inc. (None–None)

Year-by-year earnings quality comparison for Biora Therapeutics, Inc..

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.